Presenter
|
Topic
|
|
Dr. Maarten Egeler, MD, PhD
The Hospital for Sick Children
Toronto, ON Canada
|
Overview of LCH in Children
Dr. Egeler discusses an overview of Langerhans cell histiocytosis (LCH), its symptoms, diagnosis and treatment, as well as a description of the BRAF mutation and the importance of the relationship between the Histiocytosis Association and the Histiocyte Society.
Watch the Video
Return to Top |
Dr. Kimo Stine, MD
University of Arkansas
Little Rock, AR USA
|
LCH Degrees of Risk
Dr. Stine discusses the difference between the degrees of risk with LCH (low, high, and multi-system involvement). Dr. Stine also outlines what determines the length of treatment for LCH.
Watch the Video
Return to Top |
Dr. Kenneth McClain, MD, PhD
Texas Children's Hospital
Houston, TX USA
|
CNS Involvement
Dr. McClain outlines what it means to have Central Nervous System involvement (CNS) as well as the symptoms and treatment. Dr. McClain also covers the relationship between LCH and CNS, long-term effects and what patients can expect with this diagnosis.
Watch the Video
Return to Top |
Dr. K. Scott Baker, MD
Fred Hutchinson Cancer
Research Center
Seattle, WA USA |
Late Effects of LCH
Dr. Baker discusses the late effects/long term side effects of LCH and its treatment as well as any learning or behavioral issues that may arise.
Watch the Video
Return to Top |
Dr. Carlos Rodriguez-Galindo, MD
Dana-Farber Cancer Institute
Boston, MA USA
|
Overview of LCH (en Español)
¿Qué es la Histiocitosis de Célula de Langerhans (HCL) (en niños)?
¿Cuáles son los síntomas de la HCL?
¿Existe una curacón para la HCL?
Mira el vídeo
Overview of HLH (en Español)
¿Qué es la Histiocitosis Linfohistiocitica (HLH)?
¿Cuáles son los síntomas de la HLH?
¿Existe una curacón para HLH?
Mira el vídeo
|
Dr. Michael Girschikofsky, MD
Elisabethinen Hospital
Linz, Austria
|
Overview of LCH in Adults
Dr. Girschikofsky discusses an overview of LCH in Adults, current treatments, and what patients can expect moving forward after diagnosis.
Watch the Video
Return to Top
|
Dr. Robert Vassallo, MD
Mayo Clinic
Rochester, MN USA
|
Overview of Pulmonary LCH
Dr. Vassallo gives an overview of Pulmonary Langerhans cell histiocytosis (PLCH) as well as the symptoms, diagnosis, treatment and long-term effects.
Watch the Video
Return to Top
|
Dr. Michael Jordan, MD
Cincinnati Children's Hospital
Cincinnati, OH USA
|
Overview of HLH
Dr. Jordan gives an overview of hemophagocytic lymphohistiocytosis (HLH), its symptoms, diagnosis and treatment.
Watch the Video
Return to Top |
Dr. Oussama Abla, MD
The Hospital for Sick Children
Toronto, ON Canada
|
Overview of Rosai-Dorfman Disease
Dr. Abla gives an overview of Rosai-Dorfman disease, its symptoms, diagnosis and treatment.
Watch the Video
Overview of Juvenile Xanthogranuloma
Dr. Abla gives an overview of Juvenile Xanthogranuloma, its symptoms, diagnosis and treatment.
Watch the Video
|
|
Dr. Robert Arceci, MD, PhD
Phoenix Children's Hospital
Phoenix, AZ USA
|
Overview of Erdheim-Chester Disease (ECD)
Dr. Arceci gives an overview of ECD, its symptoms, diagnosis and treatment.
Watch the Video
Return to Top
|
Dr. James Whitlock, MD
The Hospital for Sick Children
Toronto, ON Canada
|
Overview of Diabetes Insipidus (DI)
Dr. Whitlock gives an overview of Diabetes Insipidus, its diagnosis and treatment.
Watch the Video
Return to Top
|
Dr. Thomas Gross, MD, PhD
National Cancer Institute
Rockville, MD USA
|
Importance of Clinical Trials
Dr. Gross reviews the importance of clinical trials for patients as well as for the future of histiocytic research, the challenges associated with trials and how you or your physician can learn more about ongoing clinical trials.
Watch the Video
Return to Top
|
Dr. Carl Allen, MD, PhD
Texas Children's Cancer Center
Baylor College of Medicine
Houston, TX USA |
Scientific Research Review Process
Dr. Allen discusses the role of the Histiocyte Society Scientific Committee in the Histiocytosis Association's competitive grant application process. Dr. Allen also discusses the grading criteria and the importance of this type of funding process.
Watch the Video
Return to Top |